CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue UDR Q1 2026 Earnings Massive EPS Beat Drives Modest Stock Uplift GEMI Q1 2026 Earnings Narrowed Loss Per Share Surprises to the Upside ABT Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Lower RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending Perella Weinberg Partners Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Headwinds